Asthma, chronic obstructive pulmonary disease, or both? diagnostic labeling and spirometry in primary care patients aged 40 years or more

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 597-603

  Melbye, Hasse ^a   Drivenes, Elin ^a   Dalbak, Lene G ^b   Leinan, Tone ^a   Høegh Henrichsen, Svein ^b   Østrem, Anders ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Asthma; Copd; Diagnosis; Primary care

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; SMOKING HABIT; SPIROMETRY; SYNDROME DELINEATION; AGE; AGED; CHI SQUARE DISTRIBUTION; DIFFERENTIAL DIAGNOSIS; LUNG; MIDDLE AGED; NORWAY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; REGISTER; VITAL CAPACITY;

ADULT; AGE FACTORS; AGED; ASTHMA; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; NORWAY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; SPIROMETRY; VITAL CAPACITY;

EID: 84859225489     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S25955     Document Type: Article

References (29)

1. Arif AA, Delclos GL, Lee ES, et al. Prevalence and risk factors of asthma and wheezing among US adults: an analysis of the NHANES III data. Eur Respir J. 2003;21:827-833.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765-773.
3. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370:741-750.
4. White P. Prevalence of COPD in primary care: no room for complacency. Fam Pract. 2009;26:1-2.
5. Mohangoo AD, van der Linden M W, Schellevis FG, Raat H. Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? Eur J Public Health. 2006;16:101-105.
6. Hvidsten SC, Storesund L, Wentzel-Larsen T, et al. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Clin Respir J. 2010;4:13-21.
7. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176: 532-555.
8. Selstad GM, Melbye H. Oral corticosteroids for asthma or COPD were dispensed to 2.6% of Norwegians aged 7 years or over in 2004-2005. Prim Care Respir J. 2011;20:332-333.
9. Haugan T, Bakken IJ, Storro O, et al. Utilization of diagnostic tools and health care services for obstructive lung disease. Tidsskr Nor Laegeforen. 2008;128:2431-2434.
10. Joensen L, Melbye H. Spirometry in general practice in Northern Norway. Tidsskr Nor Laegeforen. 2010;130:33-35. Norwegian.
11. Pearson M, Ayres JG, Sarno M, et al. Diagnosis of airway obstruction in primary care in the UK: the CADRE (COPD and Asthma Diagnostic/ management REassessment) programme 1997-2001. Int J Chron Obstruct Pulmon Dis. 2006;1:435-443.
12. Tinkelman DG, Price DB, Nordyke RJ, Halbert RJ. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. J Asthma. 2006;43:75-80.
13. van der Molen T, Willemse B W, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
15. Langhammer A, Johnsen R, Gulsvik A, et al. Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trondelag Study. Eur Respir J. 2001;18:770-779.
16. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Spirometry for health care providers. Available from: http://www. gpcme.co.nz/pdf/GOLD%20SpirometryFull%5B1%5D.pdf. Accessed October 11, 2011.
17. Walker P P, Mitchell P, Diamantea F, et al. Effect of primarycare spirometry on the diagnosis and management of COPD. Eur Respir J. 2006;28:945-952.
18. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 10 A.D; 1997.
19. Medbo A, Melbye H. Lung function testing in the elderly: can we still use FEV(1)/FVC, 70% as a criterion of COPD? Respir Med. 2007;101: 1097-1105.
20. Schneider A, Gindner L, Tilemann L, et al. Diagnostic accuracy of spirometry in primary care. BMC Pulm Med. 2009;9:31.
21. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2009;9:409-416.
22. Rogliani P, Curradi G, Mura M, et al. Metabolic syndrome and risk of pulmonary involvement. Respir Med. 2010;104:47-51.
23. Light RW, George RB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med. 1983;143:429-433.
24. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinfation in COPD. COPD. 2006;3:219-232.
25. Rothe T. True restrictive ventilatory pattern in asthma. J Asthma. 2010;47:594-596.
26. Miller A, Palecki A. Restrictive impairment in patients with asthma. Respir Med. 2007;101:272-276.
27. Gudmundsson G, Cerveny M, Shasby DM. Spirometric values in obese individuals. Effects of body position. Am J Respir Crit Care Med. 1997;156:998-999.
28. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143-178.
29. Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med. 2006;6:S4.